Surgery followed by radiotherapy in endometrial cancer: Analysis of survival and patterns of failure

International Journal of Gynecological Cancer

Volumn 9, Issue 4, 1999, Pages 285-294

  Jereczek Fossa, B ^a,b   Badzio, A ^a   Jassem, J ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Endometrial carcinoma; Patterns of failure; Postoperative radiotherapy; Prognostic factors

Indexed keywords

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; ENDOMETRIUM CANCER; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; PELVIS CANCER; PRIORITY JOURNAL; PROGNOSIS; TREATMENT FAILURE;

EID: 0032772374     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1999.99038.x     Document Type: Article

References (77)

1. Boring CC, Squires TS, long T, Montgomery S. Cancer statistics. Ca J Clin 1994;44:7-26.
2. Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma. Obstet Gynecol 1980;56:419-26.
3. Elliott P, Green D, Coates A et al. The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer. Int J Gynecol Cancer 1994;4: 84-93.
4. Nori D, Hilaris BS, Tome M, Lewis JL, Birnbaum S, Fuks Z. Combined surgery and radiation in endometrial carcinoma: an analysis of prognostic factors. Int J Radiat Oncol Biol Phys 1987;13:489-97.
5. Podczaski E, Kaminski P, Gurski K et al. Detection and patterns of treatment failure in 300 consecutive cases of 'early' endometrial cancer after primary surgery. Gynecol Oncol 1992;47:323-7.
6. Creutzberg CL, van Putten WLJ, Koper PCM et al. Postoperative radiotherapy in pT1 endometrial carcinoma: Results from a prospective randomized trial in 715 patients. Radiother Oncol 1998;48 (Suppl. 1):S78 (Abstract).
7. Boz G, De Paoli A, Innocente R et al. Endometrial stage I carcinoma treated with surgery and adjuvant irradiation: a retrospective analysis. Tumori 1995;81:256-60.
8. Carl UM, Bahsen J, Edel B, Chandra A. The value of a postoperative radiation therapy in FIGO stage I and II endometrial cancers. Strahlenther Onkol 1995;171:322-5.
9. Rush S, Gal D, Potters L, Bosworth J, Lovecchio J. Pelvic control following external beam irradiation for surgical stage I endometrial adenocarcinoma. Int J Radiat Oncol Biol Phys 1995;33:851-4.
10. Kodama S, Kase H, Tanaka K, Matsui K. Multivariate analysis of prognostic factors in patients with endometrial cancer, Int J Gynecol Obstet 1996;53:23-30.
11. Stryker JA, Podczaski E, Kaminski P, Velkley DE. Adjuvant external beam therapy for pathologic stage I and occult stage II endometrial carcinoma. Cancer 1991;67: 2872-9.
12. Torrisi JR, Barnes WA, Popescu G et al. Postoperative adjuvant external-beam radiotherapy in surgical stage I endometrial carcinoma. Cancer 1989;64:1414-7.
13. Bliss P, Cowie VJ. Endometrial carcinoma: does the addition of intracavitary vault caesium to external beam therapy postoperatively result in improved control or increased morbidity? Clin Oncol 1992;4:373-6.
14. Greven KM, Randall M, Fanning J et al. Patterns of failure in patients with stage I, grade 3 carcinoma of the endometrium. Int J Radiat Oncol Biol Phys 1990;19:529-34.
15. Corn BW, Lanciano RM, D'Agostino R et al. The relationship of local and distant failure from endometrial cancer: defining a clinical paradigm. Gynecol Oncol 1997;66: 411-6.
16. Kucera H, Vavra N, Weghaupt K. Benefit of external irradiation in pathologic stage I endometrial carcinoma; a prospective clinical trial of 605 patients who received postoperative vaginal irradiation and additional pelvic irradiation in the presence of unfavorable prognostic factors. Gynecol Oncol 1990;38:99-104.
17. Barhum M, Stein M, Rosenblatt E, Dale J, Kuten A. Pathological stage I endometrial carcinoma: the role for adjuvant radiotherapy. Tumori 1993;79:405-9.
18. Descamps P, Calais G, Moire C et al. Predictors of distant recurrence in clinical stage I or II endometrial carcinoma treated by combination surgical and radiation therapy. Gynecol Oncol 1997;64:54-8.
19. Fanning J, Nanavati PJ, Hilgers RD. Surgical staging and high dose rate brachytherapy for endometrial cancer: limiting external radiotherapy to node-positive tumors. Obstet Gynecol 1996;87:1041-4.
20. Maggino T, Romagnolo C, Zola P, Sartori E, Landoni F, Gadducci A. An analysis of approaches to the treatment of endometrial cancer in Western Europe: a CTF study. Eur J Cancer 1995;31A:193-7.
21. FIGO. Stages. 1988 revision. Gynecol Oncol 1989;35:125-7.
22. Jereczek-Fossa B, Jassem J, Nowak R, Badzio A. Late complications after postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases with application of linear-quadratic model, Int J Radiat Oncol Biol Phys 1998;41:329-38.
23. Perez CA, Brady LW. Quantification of treatment toxicity. In: Perez CA, Brady LW. eds. Principles and Practice of Radiation Oncology Philadelphia: JB Lippincott, 1992: 51-5.
24. LENT SOMA. Tables. Radiother Oncol 1995;35:17-60.
25. Zaino RJ, Kurman RJ, Diana KL, Morrow CP. Pathologic models to predict outcome for women with endometrial adenocarcinoma. Cancer 1996;77:1115-21.
26. Wolfson AH, Sightler SE, Markoe AM et al. The prognostic significance of surgical staging for carcinoma of the endometrium. Gynecol Oncol 1992;45:142-6.
27. Lewandowsky G, Torrisi J, Potkul RK et al. Hysterectomy with extended surgical staging and radiotherapy versus hysterectomy alone and radiotherapy in stage I endometrial cancer. Gynecol Oncol 1990;36:401-4.
28. Kaku T, Tsukamoto N, Hachisuga T et al. Endometrial carcinoma associated with hyperplasia. Gynecol Oncol 1996;60:22-5.
29. Pettersson F. Annual report on the results of treatment in gynecological cancer, Stockholm: International Federation of Gynecology and Obstetrics 1996, 22.
30. Carey MS, O'Connel GJ, Johanson CR et al. Good outcome associated with standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol 1995;57:138-44.
31. Meerwaldt JH, Hoekstra JM, van Putten WLJ, Subandono Tjokrowardojo AJ, Koper PCM. Endometrial adenocarcinoma, adjuvant radiotherapy tailored to prognostic factors, Int J Radiat Oncol Biol Phys 1990;18:299-304.
32. Piver MS, Hempling RE. A prospective trial of postoperative vaginal radium/cesium for grade 1-2 less than 50% myometrial invasion and pelvic radiation therapy for grade 3 or deep myometrial invasion in surgical stage I endometrial adenocarcinoma. Cancer 1990;66:1133-8.
33. Ayhan A, Tuncer ZS, Tuncer R, Yuce K, Kucukali T. Risk factors for recurrence in clinically early endometrial carcinoma: an analysis of 183 consecutive cases. Eur J Obstet Gynecol 1994;57:167-70.
34. Wang M, Hussey DH, Vigliotti APG et al. Inoperable adenocarcinoma of endometrium: radiation therapy. Radiology 1987;65:561-5.
35. Grigsby PW, Perez CA, Kuten A et al. Clinical stage I endometrial cancer: results of adjuvant irradiation and patterns of failure, Int J Radiat Oncol Biol Phys 1991;21: 379-85.
36. Bedwinek J, Galakatos A, Camel M, Kao M, Stokes S, Carlos C. Stage I, grade III adenocarcinoma of the endometrium treated with surgery and irradiation. Cancer 1984;54:40-7.
37. Pettersson B, Jansson H, Nilsson A, Schmidt M, Stenson S. Prophylactic vaginal irradiation with low dose rate afterloading technique in women with endometrial cancer. In: Mould RF, ed. Brachytherapy 2. Leersum: Nucletron International BV, 1989: 240-4 (Abstract).
38. Randall ME, Wilder J, Greven K, Raben M. Role of intracavitary cuff boost after adjuvant external irradiation in early endometrial carcinoma, Int J Radiat Oncol Biol Phys 1990;19:49-54.
39. Stokes S, Bedwinek J, Breaux S, Kao M, Camel M, Perez CA. Treatment of stage I adenocarcinoma of the endometrium by hysterectomy and irradiation: analysis of complications. Obstet Gynecol 1985;65:86-92.
40. Peters LJ, Goepfert H, Ang KK et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 1993;26:3-11.
41. Mayr NA, Wen B, Benda JA et al. Postoperative radiation therapy in clinical stage I endometrial cancer: corpus, cervical, and lower uterine segment involvement - patterns of failure. Radiology 1995;196:323-8.
42. Berek JS, Hacker NF, Hatch KD, Young CR. Uterine corpus and cervical cancer. Curr Probl Cancer 1988;12:61-71.
43. Burke TW, Wolfson AH. Limited endometrial carcinoma: adjuvant therapy. Semin Oncol 1994;21:84-9.
44. Marchetti DL, Caglar H, Driscoll DL, Hreshchyshyn MM. Pelvic radiation in stage I endometrial adenocarcinoma with high-risk attributes. Gynecol Oncol 1990;37:51-4.
45. Ackerman I, Malone S, Thomas G, Franssen E, Balogh J, Dembo A. Endometrial carcinoma - relative effectiveness of adjuvant irradiation vs therapy reserved for relapse. Gynecol Oncol 1996;60:177-83.
46. Sears JD, Greven KM, Hoen HM, Randall ME. Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer. Cancer 1994;74:1303-8.
47. Hoestra CJM, Koper PCM, van Putten WLJ. Recurrent endometrial adenocarcinoma after surgery alone: prognostic factors and treatment. Radiother Oncol 1993;27: 164-6.
48. Maciejewski B, Withers HR, Taylor JM, Hliniak A. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: Tumor dose-response and repopulation. int J Radiat Oncol Biol Phys 1989;16: 831-43.
49. Fowler JF, Lindstrom MJ. Loss of control with prolongation in radiotherapy. Int J Radial Oncol Biol Phys 1992; 23:457-67.
50. Lanciano RM, Pajak TF, Matrz K, Hanks GE. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: a patterns-of-care study. Int J Radiat Oncol Biol Phys 1993;25: 391-7.
51. Ahmad NR, Lanciano RM, Corn BW, Schulthesis T. Postoperative radiation therapy for surgically staged endometrial cancer: Impact of time factors (overall treatment time and surgery-to-radiation interval) on outcome, Int J Radial Oncol Biol Phys 1995;33:837-42.
52. Morris M, Alvarez RD, Kinney WK, Wilson TO. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration. Gynecol Oncol 1996;60:288-91.
53. Pierga J-Y, Dieras V, Dorval T et al. Treatment of advanced or recurrent endometrial carcinoma with combination of etoposide, cisplatin, and 5-fluorouracil: a phase II study. Gynecol Oncol 1996;60:59-63.
54. Abeler V, Kjorstad KE, Nesland JM. Undifferentiated carcinoma of the endometrium: a histopathologic and clinical study of 31 cases. Cancer 1991;68:98-105.
55. Lybeert ML, van Putten WLJ, Ribot JG, Crommelin MA. Endometrial carcinoma: high dose-rate brachytherapy combination with external irradiation; A multivariate analysis of relapses. Radiother Oncol 1989;16:245-52.
56. Morrow CP, Bundy BN, Kurman RJ et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol 1991;40:55-65.
57. Hoffman K, Nekhlyudov L, Deligdisch L. Endometrial carcinoma in elderly women. Gynecol Oncol 1995;58:198-201.
58. Fanning JDO, Alvarez PM, Tsukada Y, Piver MS. Prognostic significance of the extent of cervical involvement by endometrial cancer. Gynecol Oncol 1991;40:46-7.
59. Tornos C, Silva EG, El-Naggar A, Burke TW. Aggressive stage I grade 1 endometrial carcinoma. Cancer 1992;70: 790-8.
60. Hamel NW, Sebo TJ, Wilson TO et al. Prognostic value of p53 and proliferating cell nuclear antigen expression in endometrial carcinoma. Gynecol Oncol 1996;62:192-8.
61. Kadar NR, Malfetano JH, Homesley HD. Steroid receptor concentrations in endometrial carcinoma; effect on survival in surgically staged patients. Gynecol Oncol 1993;50: 281-6.
62. Leminen A, Forss M, Lehtovirta P. Endometrial adenocarcinoma with clinical evidence of cervical involvement: accuracy of diagnostic procedures, clinical course, and prognostic factors. Acta Obstet Gynecol Scand 1995; 74:61-6.
63. Lanciano RM, Curran WJ, Greven KM et al. Influence of grade, histologic subtype, and timing of radiotherapy on outcome among patients with stage II carcinoma of the endometrium. Gynecol Oncol 1990;39:368-73.
64. Abeler V, Kjorstad KE. Serous papillary carcinoma of the endometrium: a histopathological study of 22 cases. Gynecol Oncol 1990;39:266-71.
65. Abeler V, Kjorstad KE. Clear cell carcinoma of the endometrium: a histopathological and clinical study of 97 cases. Gynecol Oncol 1991;40:207-17.
66. Homesley HD. Management of endometrial cancer. Am J Obstet Gynecol 1996;174:529-34.
67. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer 1987;60:2035-41.
68. De Palo G, Mangioni C, Periti P, Del Vecchio M, Marubini E. Treatment of FIGO (1971) stage I endometrial carcinoma with intensive surgery, radiotherapy and hormonotherapy according to pathological prognostic groups. Long-term results of a randomised multicentre study. Eur J Cancer 1993;29A:1133-40.
69. Morrow CP, Bundy BN, Homesley HD et al. Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II. A Gynecologic Oncology Group study. Gynecol Oncol 1990;36:166-71.
70. Stringer CA, Gershenson DM, Burke TW, Edwards CL, Gordon AN, Wharton JT. Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early-stage high-risk endometrial cancer: a preliminary analysis. Gynecol Oncol 1990;38:305-8.
71. Schunemann H, Jourdain M. Double and triple neoplasms in endometrial carcinoma, Zentralbl Gynakol 1994;116:522-6.
72. Bucy GS, Mendenhall WM, Morgan LS et al. Clinical stage I and II endometrial carcinoma treated with surgery and/or radiation therapy: analysis of prognostic and treatment-related factors. Gynecol Oncol 1989;33: 290-5.
73. Tiitinen A, Forss M, Aho I, Vesterinen E, Nieminen U. Endometrial adenocarcinoma: Clinical outcome in 881 patients and analysis of 146 patients whose deaths were due to endometrial cancer. Gynecol Oncol 1986;25:11-9.
74. Maneschi M, Maneschi F, Geraci P et al. Surgical pathological staging of endometrial carcinoma and results of treatment. Eur J Gynaecol Oncol 1992;13:30-5.
75. Reisinger SA, Staros EB, Feld R, Mohiuddin M, Lewis GC. Preoperative radiation therapy in clinical stage II endometrial carcinoma. Gynecol Oncol 1992;45:174-8.
76. Kadar NR, Malfetano JH, Homesley HD. Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: Implications for therapy. Obstet Gynecol 1992;80:655-9.
77. Kilgore LC, Partridge ED, Alvarez RD et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 1995;56:29-33.